Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B Stock, NASDAQ:LGND
3911 Sorrento Valley Boulevard, Suite 110, San Diego, California 92121
United States of America
Number of Employees: 155
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.